eHealth Financial Statements (EHTH) |
||||||||||
eHealthsmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 08.08.2023 | 09.11.2023 | 27.02.2024 | 29.02.2024 | 07.05.2024 | 07.05.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 66.8 | 64.7 | 247.7 | 247.7 | 93.0 | 653.0 | |||
Operating Income, bln rub | -26.2 | -39.4 | 59.4 | 59.4 | -17.9 | 61.4 | ||||
EBITDA, bln rub | ? | -21.0 | -39.4 | 64.1 | 64.1 | -17.9 | 71.0 | |||
Net profit, bln rub | ? | -23.5 | -47.2 | 52.2 | 52.2 | -27.7 | 29.4 | |||
OCF, bln rub | ? | -9.43 | -24.7 | -33.4 | -33.4 | 70.8 | -20.7 | |||
CAPEX, bln rub | ? | 2.34 | 4.21 | 1.99 | 1.99 | 0.000 | 8.20 | |||
FCF, bln rub | ? | -11.8 | -28.9 | -35.4 | -35.4 | 70.8 | -28.9 | |||
Dividend payout, bln rub | 0.873 | 0.000 | 2.66 | 2.66 | 0.000 | 5.32 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
Dividend payout ratio, % | 0.00% | 0.00% | 5.10% | 5.10% | 0.00% | 18.1% | ||||
OPEX, bln rub | 92.7 | 103.9 | 182.4 | 182.4 | 71.7 | 540.4 | ||||
Cost of production, bln rub | 0.253 | 0.194 | 5.88 | 5.88 | 0.000 | 12.0 | ||||
R&D, bln rub | 14.5 | 13.8 | 17.2 | 17.2 | 13.3 | 61.4 | ||||
Interest expenses, bln rub | 0.000 | 0.000 | 2.85 | 2.85 | 2.81 | 8.51 | ||||
Assets, bln rub | 1 053 | 1 026 | 1 113 | 1 316 | 1 096 | 1 096 | ||||
Net Assets, bln rub | ? | 880.9 | 848.5 | 904.1 | 904.1 | 582.8 | 582.8 | |||
Debt, bln rub | 104.3 | 104.4 | 103.2 | 103.2 | 101.7 | 101.7 | ||||
Cash, bln rub | 189.8 | 160.6 | 121.7 | 121.7 | 188.9 | 188.9 | ||||
Net debt, bln rub | -85.5 | -56.2 | -18.5 | -18.5 | -87.2 | -87.2 | ||||
Ordinary share price, rub | 8.04 | 7.40 | 8.72 | 8.72 | 8.82 | |||||
Number of ordinary shares, mln | 27.8 | 28.1 | 29.4 | 28.5 | 0.000 | 0.000 | ||||
Market cap, bln rub | 224 | 208 | 256 | 248 | 0 | 0 | ||||
EV, bln rub | ? | 138 | 152 | 238 | 230 | -87 | -87 | |||
Book value, bln rub | 881 | 849 | 904 | 272 | 583 | 583 | ||||
EPS, rub | ? | -0.84 | -1.68 | 1.78 | 1.83 | |||||
FCF/share, rub | -0.42 | -1.03 | -1.20 | -1.24 | ||||||
BV/share, rub | 31.7 | 30.2 | 30.8 | 9.56 | ||||||
EBITDA margin, % | ? | -31.5% | -60.9% | 25.9% | 25.9% | -19.3% | 10.9% | |||
Net margin, % | ? | -35.2% | -73.0% | 21.1% | 21.1% | -29.8% | 4.51% | |||
FCF yield, % | ? | -3.73% | -1.66% | -6.82% | -7.04% | 0.00% | ||||
ROE, % | ? | -7.02% | -8.24% | -4.25% | -4.25% | -7.94% | 5.05% | |||
ROA, % | ? | -5.87% | -6.82% | -3.45% | -2.92% | -4.22% | 2.69% | |||
P/E | ? | -3.62 | -2.97 | -6.66 | -6.46 | 0.00 | 0.00 | |||
P/FCF | -26.8 | -60.4 | -14.7 | -14.2 | 0.00 | 0.00 | ||||
P/S | ? | 0.57 | 0.52 | 0.57 | 0.55 | 0.00 | 0.00 | |||
P/BV | ? | 0.25 | 0.25 | 0.28 | 0.91 | 0.00 | 0.00 | |||
EV/EBITDA | ? | -7.53 | -6.32 | -17.1 | -16.5 | 6.16 | -1.23 | |||
Debt/EBITDA | 4.66 | 2.34 | 1.33 | 1.33 | 6.16 | -1.23 | ||||
R&D/CAPEX, % | 618.6% | 328.3% | 861.2% | 861.2% | 749.7% | |||||
CAPEX/Revenue, % | 3.51% | 6.51% | 0.80% | 0.80% | 0.00% | 1.26% | ||||
eHealth shareholders |